Literature DB >> 7881604

Seroprevalence of herpes simplex virus infections in a family medicine clinic.

L Oliver1, A Wald, M Kim, J Zeh, S Selke, R Ashley, L Corey.   

Abstract

OBJECTIVES: To determine the prevalence of herpes simplex virus (HSV) antibody in a general medical practice setting and to assess the frequency of subclinical infection.
DESIGN: Prevalence study.
SETTING: A family practice clinic at the University of Washington Medical Center, Seattle. PARTICIPANTS: Five hundred randomly selected patients between the ages of 18 and 45 years. MAIN OUTCOME MEASURES: Serum samples were tested by Western blot assay to detect the presence of antibody to HSV type 1 (HSV-1) and HSV-2. Demographic information and clinical history of oral and genital herpes were obtained.
RESULTS: One hundred fourteen patients (23%) were seropositive for HSV-2 antibody, 277 patients (56%) were seropositive for HSV-1 antibody, 59 patients (12%) were seropositive for both HSV-2 and HSV-1 antibodies, and 163 patients (33%) were seronegative for both. Women were almost twice as likely as men to be seropositive for HSV-2 antibody (28% vs 15%, P < .001). Blacks had the highest rates of HSV-2 antibody seropositivity (60%) compared with whites (20%) and Asians (6%) (P < .001). Other demographic correlates of seropositivity included being older, having fewer years of education, and having public insurance. The specificity of a clinical history of genital herpes or sores for HSV-2 infection was high (99%), but the sensitivity was low (27%).
CONCLUSIONS: Herpes simplex virus infection is common among patients seeking primary care. Women, blacks, and patients of lower socioeconomic status are most likely to be seropositive for HSV-2 antibody. The high frequency of unrecognized HSV infection has implications for primary care physicians in counseling patients regarding HSV infection and transmission.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7881604     DOI: 10.1001/archfami.4.3.228

Source DB:  PubMed          Journal:  Arch Fam Med        ISSN: 1063-3987


  6 in total

1.  HSV type specific antibody tests: patients are ready, are clinicians?

Authors:  R L Ashley; L Corey
Journal:  Genitourin Med       Date:  1997-08

2.  Rising incidence and prevalence of herpes simplex type 2 infection in a cohort of 26 year old New Zealanders.

Authors:  J E Eberhart-Phillips; N P Dickson; C Paul; G P Herbison; J Taylor; A L Cunningham
Journal:  Sex Transm Infect       Date:  2001-10       Impact factor: 3.519

3.  Imiquimod 5-percent cream does not alter the natural history of recurrent herpes genitalis: a phase II, randomized, double-blind, placebo-controlled study.

Authors:  Timothy W Schacker; Marcus Conant; Christopher Thoming; Tamara Stanczak; Zengri Wang; Michael Smith
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

Review 4.  Genital herpes: review of the epidemic and potential use of type-specific serology.

Authors:  R L Ashley; A Wald
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

5.  Bayesian Evaluation of Solana HSV 1+2/VZV Assay Compared to Viral Culture and Commercial PCR Assay for Cutaneous or Mucocutaneous Specimens.

Authors:  Christine Arsenault; Félix Camirand Lemyre; Philippe Martin; Simon Lévesque
Journal:  J Clin Microbiol       Date:  2020-02-24       Impact factor: 5.948

Review 6.  Macrophages and cytokines in the early defence against herpes simplex virus.

Authors:  Svend Ellermann-Eriksen
Journal:  Virol J       Date:  2005-08-03       Impact factor: 4.099

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.